Clinical trial
An Open-label Study to Compare the Pharmacokinetic Profiles of a Single Dose of Ferriprox in Subjects With Impaired Renal Function and Healthy Volunteers
NCT01770652 is registered in ClinicalTrials.gov with ApoPharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Study to Compare the Pharmacokinetic Profiles of a Single Dose of Ferriprox in Subjects With Impaired Renal Function and Healthy Volunteers
- Lead sponsor
- ApoPharma
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2013
- Completion date
- August 31, 2013
- Enrollment
- 32 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
renal impairment